World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
100
Citations
41817
World Ranking
720
National Ranking
412

Medicine

D-Index
100
Citations
41861
World Ranking
8214
National Ranking
4257

Marcel R.M. van den Brink publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marcel R.M. van den Brink sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 512 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marcel R.M. van den Brink D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marcel R.M. van den Brink sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 100 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2020 - Royal Netherlands Academy of Arts and Sciences

Overview

Marcel R.M. van den Brink is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medical and biomedical fields with a strong emphasis on hematology, oncology, and immunology, as reflected in their extensive publication record.

Their main fields of study include Medicine, with specific subfields such as:

  • Oncology
  • Molecular Biology
  • Immunology
  • Hematology
  • Infectious Diseases

Their research covers key topics including:

  • Hematopoietic Stem Cell Transplantation
  • Gut microbiota and health
  • CAR-T cell therapy research
  • Neutropenia and Cancer Infections
  • Immune Cell Function and Interaction
  • Clostridium difficile and Clostridium perfringens research
  • T-cell and B-cell Immunology

Some recent papers authored or coauthored by Marcel R.M. van den Brink are:

  • Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation, 2020, New England Journal of Medicine
  • The gut microbiota is associated with immune cell dynamics in humans, 2020, Nature
  • Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites, 2020, Science
  • Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen, 2020, Nature Immunology
  • High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis, 2020, Nature Medicine

The scientist has frequently collaborated with several researchers, including:

  • Jonathan U. Peled
  • Miguel-Angel Perales
  • Sergio Giralt
  • John Slingerland
  • Anqi Dai

Publications by Marcel R.M. van den Brink are often found in prominent journals and venues such as:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Transplantation and Cellular Therapy
  • Journal of Clinical Oncology
  • Biology of Blood and Marrow Transplantation

In 2020, Marcel R.M. van den Brink was recognized by the Royal Netherlands Academy of Arts and Sciences.

Best Publications

  • ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

    Daniel W. Lee;Bianca D. Santomasso;Frederick L. Locke;Armin Ghobadi

  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

    Jay P. Patel;Mithat Gönen;Maria E. Figueroa;Hugo Fernandez

  • Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

    Charlie G. Buffie;Vanni Bucci;Vanni Bucci;Richard R. Stein;Peter T. McKenney

  • Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration

    Caroline A. Lindemans;Caroline A. Lindemans;Marco Calafiore;Anna M. Mertelsmann;Margaret H. O'Connor

  • Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Ying Taur;Joao B. Xavier;Lauren Lipuma;Carles Ubeda

  • Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans

    Carles Ubeda;Ying Taur;Robert R. Jenq;Michele J. Equinda

  • Interleukin-22: Immunobiology and Pathology

    Jarrod A Dudakov;Alan M Hanash;Marcel R M van den Brink

  • The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

    Ying Taur;Ying Taur;Robert R Jenq;Robert R Jenq;Miguel Angel Perales;Miguel Angel Perales;Eric R. Littmann

  • Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

    Robert R. Jenq;Robert R. Jenq;Ying Taur;Ying Taur;Sean M. Devlin;Doris M. Ponce;Doris M. Ponce

  • Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.

    Nathan D. Mathewson;Robert R Jenq;Anna V. Mathew;Mark Koenigsknecht

  • Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

    Jonathan U Peled;Antonio L C Gomes;Sean M Devlin;Eric R Littmann

  • Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

    Robert R. Jenq;Robert R. Jenq;Carles Ubeda;Carles Ubeda;Ying Taur;Ying Taur;Clarissa C. Menezes

  • Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

    Alan M. Hanash;Jarrod A. Dudakov;Guoqiang Hua;Margaret H. O’Connor

  • Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

    Yusuke Shono;Melissa D. Docampo;Jonathan U. Peled;Jonathan U. Peled;Suelen M. Perobelli

  • Thymic involution and immune reconstitution

    Heather E Lynch;Gabrielle L Goldberg;Ann Patricia Chidgey;Marcel R M van den Brink

  • The gut microbiota is associated with immune cell dynamics in humans.

    Jonas Schluter;Jonathan U. Peled;Jonathan U. Peled;Bradford P. Taylor;Kate A. Markey;Kate A. Markey

  • Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization

    Carles Ubeda;Carles Ubeda;Vanni Bucci;Silvia Caballero;Silvia Caballero;Ana Djukovic

  • Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites

    Hao Guo;Wei-Chun Chou;Yunjia Lai;Kaixin Liang

  • Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen.

    Santosha A. Vardhana;Madeline A. Hwee;Mirela Berisa;Daniel K. Wells

  • The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

    Kenneth R. Cooke;Leo Luznik;Stefanie Sarantopoulos;Frances T. Hakim

  • Nature's TRAIL: On a path to cancer immunotherapy

    Mark J Smyth;Kazuyoshi Takeda;Yoshihiro Hayakawa;Jacques J Peschon

  • Interleukin-22 drives endogenous thymic regeneration in mice

    Jarrod A. Dudakov;Jarrod A. Dudakov;Alan M. Hanash;Robert R. Jenq;Robert R. Jenq;Lauren F. Young

Frequent Co-Authors

Miguel-Angel Perales
Miguel-Angel Perales Memorial Sloan Kettering Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Robert R. Jenq
Robert R. Jenq The University of Texas MD Anderson Cancer Center
Eric G. Pamer
Eric G. Pamer Memorial Sloan Kettering Cancer Center
Ying Taur
Ying Taur Memorial Sloan Kettering Cancer Center
Richard J. O'Reilly
Richard J. O'Reilly Memorial Sloan Kettering Cancer Center
Chen Liu
Chen Liu Yale University
Nancy A. Kernan
Nancy A. Kernan Memorial Sloan Kettering Cancer Center
George F. Murphy
George F. Murphy Brigham and Women's Hospital
Katharine C. Hsu
Katharine C. Hsu Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many students start with foundational nursing programs, such as online absn programs for non nurses, which allow individuals without a nursing background to transition into nursing efficiently.

If you prefer a quicker route, consider 12-month accelerated nursing programs. These are designed for motivated learners aiming to obtain their Bachelor of Science in Nursing rapidly and enter the workforce sooner.

For those seeking entry-level licenses, easiest lpn programs to get into offer accessible pathways to become Licensed Practical Nurses, a vital role supporting patient care and gaining practical experience in clinical settings.

Advancing further, many professionals pursue specialized roles through the easiest nurse practitioner program options. These programs prepare nurses for advanced practice careers, often integrating immunological expertise useful in patient diagnosis and treatment planning.

Best Scientists Citing Marcel R.M. van den Brink

Trending Scientists

Recently Published Articles